Latest News on National Pharmaceutical Pricing Authority
Showing of 0 - 10 from 20 results
National Pharmaceutical Pricing Authority - Total results - 20
Feb 20, 2018
Margins on drugs as high as 1,192% in four private hospitals: NPPANon-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals with margins as high as 1,192 percent, drug pricing regulator NPPA said on Tuesday
Dec 27, 2017
Govt's cheaper medicare drive pinches pharmaceutical sector, private hospitals in 2017While the government's directive to doctors to prescribe only generic names unsettled pharma companies, the NPPA's (National Pharmaceutical Pricing Authority) move to cap prices of medical devices such as stents and knee implants created discomfort for the manufacturers.
Dec 22, 2017
NPPA sets deadline to lower prices of syringes and needles; manufacturers volunteer, set trade margin at 75%Syringe and needle manufacturers set trade margins at maximum 75 percent in an attempt to self-regulate prices; NPPA sets deadline to 26 January
Dec 15, 2017
Gurugram child dies of dengue: NPPA says Fortis overcharged patient's family by margin as high as 1700%Fortis hospital at Gurgaon charged as high as 1,700 percent margin on consumables and medicines used for the treatment of a dengue patient who subsequently died of the illness, the National Pharmaceutical Pricing Authority (NPPA) said
Nov 24, 2017
Drug price regulator caps prices of 51 essential formulations used for cancer, heart, skin treatmentNPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013
Oct 17, 2017
Donald Trump promises to reduce cost of prescription drugs in US, move may impact IndiaUS president Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy.
Sep 27, 2017
Abbott's decision to pull out Xience Alpine stent won't impact Indian patients, claim health activistsAbbott recently got the approval to withdraw Xience Alpine stent from India by the NPPA, however, health activists believe the move would benefit Indian high-end medical device makers
Aug 16, 2017
Knee implants price capped; saving to patients Rs 1,500 cr, says govtNPPA has capped the price of widely used Cromium Cobalt knee implants at Rs 54,720 from earlier Rs 1.58-Rs 2.5 lakh
May 21, 2017
Cardiac stents row: ESIC told to reveal patients referred to private hospitals after RTI applicant alleges corruptionTaking a serious view of private hospitals "fleecing" patients for cardiac stents, the Central Information Commission (CIC) has directed the Employees State Insurance Corporation (ESCI) to disclose the number of patients referred by it to private hospitals for the implants and the prices paid to those hospitals.
May 06, 2017
Nepal cashes on as India's price cap send stents disappearing from countryThe NPAA is convinced that hospitals make the highest profit on stents and — therefore — avoid audits to curb inappropriate use.